Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT07060807
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
1,000 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Neoplasms
RECRUITING
NCT04635111
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
30 Enrollment(s)
8 Study location(s)
OBSERVATIONAL (None)
Hepatotoxicity


Tenosynovial Giant Cell Tumor
ACTIVE_NOT_RECRUITING
NCT06961331
Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.
93 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Metastatic HER2+ Advanced Breast Cancer
RECRUITING
NCT06435429
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
550 Enrollment(s)
154 Study location(s)
INTERVENTIONAL (PHASE3)
Metastatic HER2-positive Breast Cancer
RECRUITING
NCT06172127
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
165 Enrollment(s)
36 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-positive Breast Cancer
RECRUITING
NCT05950945
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
250 Enrollment(s)
84 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
RECRUITING
NCT06750484
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
50 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer Metastatic
RECRUITING
NCT06610825
Castrate Resistant Prostate Cancer Enhertu Therapy
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Prostate Cancer Metastatic


Prostate Cancer


CRPC